Paper · 42579267

Short-Term Impact of Endoscopic Gastric Remodeling in Metabolic Dysfunction-Associated Steatotic Liver Disease: A Systematic Review and Meta-Analysis.

Kagzi Y and 2 others. Obes Surg, 2026. Cited by 0 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Cite this record

ConductScience Library. Short-Term Impact of Endoscopic Gastric Remodeling in Metabolic Dysfunction-Associated Steatotic Liver Disease: A Systematic Review and Meta-Analysis. Papers, record 42579267. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42579267

On this page

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title: Short-Term Impact of Endoscopic Gastric Remodeling in Metabolic Dysfunction-Associated Steatotic Liver Disease: A Systematic Review and Meta-Analysis.; PubMed
Journal: Obes Surg; PubMed
Year: 2026; PubMed
Publication types: Journal Article, Systematic Review, Meta-Analysis; PubMed
PubMed: https://pubmed.ncbi.nlm.nih.gov/42579267/; PubMed
DOI: https://doi.org/10.1007/s11695-026-08889-7; PubMed
PMC: https://pmc.ncbi.nlm.nih.gov/articles/PMC13562156/; PubMed
The journal: https://conductscience.org/library/journal-index/9106714; PubMed
Citations, by iCite: 0; iCite
Revised in PubMed: 2026-09-15; PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

Order	Author	Forename	ORCID iD
1	Kagzi Y	Yusuf	https://orcid.org/0009-0000-9062-2484
2	Asif A	Abuzar
3	Puli SR	Srinivas Reddy

Source PubMed

Topics6

NLM's MeSH indexing of the paper, its major topics first.

MeSH term	Major
Gastroplasty	Major topic
Non-alcoholic Fatty Liver Disease	Major topic
Fatty Liver	Major topic
Obesity, Morbid	Major topic
Humans
Weight Loss

Source PubMed

Grants0

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

None in this release.

Trials0

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

None in this release.

Comments and corrections0

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

None in this release.

References54

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

Order	PMID	Title	Journal	Year	In Papers	Source
1	30,896,957	Bariatric and metabolic endoscopy in the handling of fatty liver disease. A new emerging approach?	Rev Esp Enferm Dig	2019	https://conductscience.org/library/papers/30896957	PubMed
2	25,835,983	Bariatric Surgery Worldwide 2013.	Obes Surg	2015	https://conductscience.org/library/papers/25835983	PubMed
3	34,472,683	MAFLD: Renovation of clinical practice and disease awareness of fatty liver.	Hepatol Res	2022	https://conductscience.org/library/papers/34472683	PubMed
4	25,865,049	Weight Loss Through Lifestyle Modification Significantly Reduces Features of Nonalcoholic Steatohepatitis.	Gastroenterology	2015	https://conductscience.org/library/papers/25865049	PubMed
5	28,358,980	Pharmacological interventions for non-alcohol related fatty liver disease (NAFLD): an attempted network meta-analysis.	Cochrane Database Syst Rev	2017	https://conductscience.org/library/papers/28358980	PubMed
6	26,093,765	Standardized outcomes reporting in metabolic and bariatric surgery.	Surg Obes Relat Dis	2015	https://conductscience.org/library/papers/26093765	PubMed
7	40,445,858	Bariatric surgery for metabolic dysfunction-associated steatotic liver disease (MASLD): Current knowledge of mechanisms.	Hepatology	2025	https://conductscience.org/library/papers/40445858	PubMed
8	24,352,617	The effectiveness and risks of bariatric surgery: an updated systematic review and meta-analysis, 2003-2012.	JAMA Surg	2014	https://conductscience.org/library/papers/24352617	PubMed
9	35,740,949	NAFLD: Mechanisms, Treatments, and Biomarkers.	Biomolecules	2022	https://conductscience.org/library/papers/35740949	PubMed
10	11,451,790	Systematic reviews in health care: Investigating and dealing with publication and other biases in meta-analysis.	BMJ	2001	https://conductscience.org/library/papers/11451790	PubMed

1 to 10 of 54

See all 54 references

Cited by0

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 0 citations.

None in this release.

Genes0

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

None in this release.

Drugs0

The drugs whose trials, in the Pipelines release, list the paper.

None in this release.

Data0

The data bank entries PubMed's record names. Trial numbers are under Trials.

None in this release.

Data dates

The date of each source this release read.

PubMed: 2026-11-06; PubMed
iCite: 2026-11-05; iCite
PMC's ID file: 2026-11-05; PMC's ID file
NIH RePORTER's grant and paper links: 2026-11-01; NIH RePORTER's grant and paper links
Trials: 2026-11-12
Gene search: 2026-11-11
Pipelines: 2026-09-18

Sources 11

ChEMBL, through Open TargetsCC BY-SA 3.0
ClinicalTrials.govNo license stated
HGNCCC0
iCiteCC BY 4.0
NCBI GenePublic domain (US government)
NIH RePORTER's grant and paper linksPublic domain
Open TargetsCC0 1.0
PMC's ID filePublic domain (US government)
PubMedNLM's terms
PubTator 3Public domain
UniProtCC BY 4.0

Each source's terms

ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
ClinicalTrials.govnone stated
HGNCCC0: https://www.genenames.org/about/license/
iCiteCC BY 4.0
NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
PubMedNLM's terms
PubTator 3Public domain
UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/42579267

GET https://conductscience.org/api/papers/v1/42579267/references?page=2

API reference For AI assistants